ka 32 V9 .
K JAN 17 2007
510(k) Summa of Safety and Effectiveness (in accordance to 21 CFR 807.87(h
Device Name
Proprietary Device Name: BEAMAX .
Establishment Name and Registration Number of Submitter
Name: Medic SharpLight Ltd.
Registration: In process
Submission contact: Dan Laor
Sireni 6, Haifa 32972, Israel TEL: 972-4-8246632
Device Classification
Product Code: GEX
Regulation Number: 878.4810
Common Name: Pulsed light hair removal system
Classification Name: Laser surgical instrument for use in general
and plastic surgery and in dermatology. ,
Regulatory class: Class II
Reason for 510(k) Submission
Traditional 510(k) Submission
Identification of Legally Marketed Equivalent Devices ,
K033946 Lovely I (Aria)
Device Description
The BEAMAX applies thermal energy to human skin tissue. The energy is transmitted
from a flash light source. It is transmitted to the target tissue by a hand piece that is in contact with the skin (contact mode).
The device is constructed from a Man Machine Interface panel, an operating console, and
a treatment hand piece.
Indications for use
The BEAMAX is intended for aesthetic and cosmetic use. The device is specifically
| indicated for removal-of hair by using selective light energy.
Safety & Effectiveness .
The device has been designed, verified and validated complying with the 21CFR. 820.30
regulations. Bench and clinical data demonstrate that the BEMAX meets the required
specifications. No adverse affects have been detected.
Substantial Equivalency
It is Medic SharpLight opinion that the BEAMAX is substantially equivalent in terms of
, safety and effectiveness to the predicate device.

nt ences, “%
é C DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
a: Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
Medic SharpLight Ltd.
% Quasar Quality Ltd.
Mr. Dan Laor JAN 17 2007
Managing Director
6 Sireni Street
Haifa 32972 Isreal
Re: K063249
Trade/Device Name: BEAMAX
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and plastic surgery and in
dermatology
Regulatory Class: II
Product Code: GEX
Dated: November 23, 2006
Received: December 1, 2006
Dear Mr. Laor:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications for
use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce
prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that
have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic
Act (Act) that do not require approval of a premarket approval application (PMA). You may,
therefore, market the device, subject to the general controls provisions of the Act. The general
controls provisions of the Act include requirements for annual registration, listing of devices, good
manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
Hf your device is classified (see above) into either class II (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must comply
with all the Act’s requirements, including, but not limited to: registration and listing (21 CFR Part
807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the
quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product
radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Mr. Dan Laor /
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
“Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain other
general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(240) 276-3150 or at its Internet address http://www. fda.gov/cdrh/industry/support/index.html.
‘ Sincerely i.
: Mark N. Melkerson
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
: Radiological Health

Enclosure

Indications for Use
510(k) Number (itknown): JCOEG FAY
Device Name: BEAMAX
Indications For Use: The BEAMAX is intended for aesthetic and cosmetic use. The device is
specifically indicated for removal of hair by using selective light energy.
. Prescription Use: YES AND/OR Over-the-Counter Use: NO
(Part 21 CFR 801 Subpart D) (Part 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF
NEEDED)
Concurrence of C , Offige pf Device Evaluation (ODE) ‘
(Divisién gn-Off)
Divisi . :
aNew of General, Restorative,
an ; :
eurological Devices Page 1 of _/
2.4
510(k) Neraber_ IL D L) 1
ee ern eine

